The following is a summary of “Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study,” published in the ...

The 2024 Nobel Prizes in physics and chemistry were seen as a sweep for artificial intelligence (AI) tools which, at their ...

AbbVie’s ABBV stock declined almost 11% in the past month, mainly due to a recent pipeline setback. In November, AbbVie ...

Bank stocks largely boosted the Dow, as investors hope the sector could see weaker regulation in a second Trump ...

A growing body of research describes seasonal trends in psychiatric disorders, with conditions like depression, schizophrenia ...

Mental illnesses are on the rise in Pakistan, pointing to a crisis that has to be addressed on a larger scale Concern over ...

However, he warned that there was "schizophrenia" in the bond market ... A 145-year-old British industrial company is ...

“Maybe I am from another planet,” I told my friend who first suggested the idea.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They ...

Shares of AbbVie (ABBV) are sinking on Monday after the company said two mid-stage trials of its investigative treatment for adults with schizophrenia missed their primary endpoints. AbbVie’s ...

AbbVie (ABBV) shares dip for 7th day, but analysts see buying opportunity after recent setback in schizophrenia drug trials.